Evidence map›Paper›PMID 33355691›Full record

ArticleJournal of neural transmission (Vienna, Austria : 1996)2021

Altered urinary tetrahydroisoquinoline derivatives in patients with Tourette syndrome: reflection of dopaminergic hyperactivity?

Philipp Capetian, Veit Roessner, Caroline Korte, Susanne Walitza, Franz Riederer, Regina Taurines, Manfred Gerlach, Andreas Moser

Open access · hybridAbstract read
In one paragraph

Article in Journal of neural transmission (Vienna, Austria : 1996), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Philipp CapetianDepartment of Neurology, University Hospital of Wuerzburg, Würzburg, Germany. capetian_p@ukw.de.ORCID http://orcid.org/0000-0003-1712-3659
Veit RoessnerDepartment of Child and Adolescent Psychiatry, TU Dresden, Dresden, Germany.
Caroline KorteDepartment of Neurology, CBBM, University of Luebeck, Luebeck, Germany.
Susanne WalitzaDepartment of Child and Adolescent Psychiatry and Psychotherapy, University of Zuerich, Zuerich, Switzerland.
Franz RiedererDepartment of Neurology, Clinic Hietzing, Vienna, Austria.
Regina TaurinesDepartment of Child and Adolescent Psychiatry, University Hospital of Wuerzburg, Würzburg, Germany.
Manfred GerlachDepartment of Child and Adolescent Psychiatry, University Hospital of Wuerzburg, Würzburg, Germany.
Andreas MoserDepartment of Neurology, CBBM, University of Luebeck, Luebeck, Germany.
Universitätsklinikum Würzburg · DEUniversity of Lübeck · DEKlinik Hietzing · ATTechnische Universität Dresden · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tetrahydroisoquinolines (TIQs) such as salsolinol (SAL), norsalsolinol (NSAL) and their methylated derivatives N-methyl-norsalsolinol (NMNSAL) and N-methyl-salsolinol (NMSAL), modulate dopaminergic neurotransmission and metabolism in the central nervous system. Dopaminergic neurotransmission is thought to play an important role in the pathophysiology of chronic tic disorders, such as Tourette syndrome (TS). Therefore, the urinary concentrations of these TIQ derivatives were measured in patients with TS and patients with comorbid attention-deficit/hyperactivity disorder (TS + ADHD) compared with controls. Seventeen patients with TS, 12 with TS and ADHD, and 19 age-matched healthy controls with no medication took part in this study. Free levels of NSAL, NMNSAL, SAL, and NMSAL in urine were measured by a two-phase chromatographic approach. Furthermore, individual TIQ concentrations in TS patients were used in receiver-operating characteristics (ROC) curve analysis to examine the diagnostic value. NSAL concentrations were elevated significantly in TS [434.67 ± 55.4 nmol/l (standard error of mean = S.E.M.), two-way ANOVA, p < 0.0001] and TS + ADHD patients [605.18 ± 170.21 nmol/l (S.E.M.), two-way ANOVA, p < 0.0001] compared with controls [107.02 ± 33.18 nmol/l (S.E.M.), two-way ANOVA, p < 0.0001] and NSAL levels in TS + ADHD patients were elevated significantly in comparison with TS patients (two-way ANOVA, p = 0.017). NSAL demonstrated an AUC of 0.93 ± 0.046 (S.E.M) the highest diagnostic value of all metabolites for the diagnosis of TS. Our results suggest a dopaminergic hyperactivity underlying the pathophysiology of TS and ADHD. In addition, NSAL concentrations in urine may be a potential diagnostic biomarker of TS.

Indexed as

Attention Deficit Disorder with HyperactivityTetrahydroisoquinolinesTic DisordersTourette SyndromeHumansTetrahydroisoquinolinesADHDBiomarkersTetrahydroisoquinoline derivatesTicsTourette syndrome

Identifiers

PMID33355691
PMCPMC7815570
OpenAlexW3118147454

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.